Internal Medicine

An analysis of data from 2013-2015 provides insight into the impact of Medicaid expansion under the Affordable Care Act on rate of major diabetes-related amputations and suggests a shift in the distribution of uninsured patients may have driven reductions observed in the study.

Cross-sectional analysis of national survey data suggest students with multiple marginalized identities are more prone to treatment that could lead to burnout.

Patients with Fabry disease who received treatment with PRX-102 every 4 weeks displayed a stable condition at the end of the trial.

Dr. Bajona highlights the patient risks of HCM, new advances in treatment options, and the importance of screening efforts.

In 2020 many clinics shifted to telehealth or reduced-contact practices which applied to medication abortions. Physicians relied solely on history-based screening instead of ultrasonography or pelvic exams during this time and investigators analyzed the data.

A user fee goal date of August 17, 2022 has been assigned to teplizumab.

Overall tobacco use declined among adults since 2019—but many from varying sociodemographic backgrounds are still reporting high use.

After more promising long-term data, Apellis announced plans to seek regulatory approval. An investigator explains what value it could bring to patients.

Phase 3 data show the C3 inhibitors' sustained benefit for the common form of vision loss. A primary author explains the significance of the new findings.

After a review of the available evidence, the USPSTF concluded there was insufficient evidence to provide recommendations on screening for eating disorders among adults and adolescents.

New data show the highest quintile of census-reported parental income is far more represented among future physicians than lower income levels, regardless of race.

ChristianaCare’s Gene Editing Institute experts join the podcast to discuss the latest developments in gene editing.

USPSTF experts noted a need for research into the benefits and harms of screening adults and adolescents without signs or symptoms.

As influenza A(H3N2) remains the most prevalent subtype in the US, investigators estimated the available flu shot is not significantly preventing positive cases.

Using multiple composite scores to assess dietary quality, investigators use data from 9 NHANES cycles to provide an overview of the declining diet quality among older adults in the US from 2001-2018.

Primary results from these 2 phase 3 trials demonstrated efficacy and safety of the biologic through 16 weeks in patients with atopic dermatitis, but longer-term outcomes remained unknown.

The clinical trial of efanesoctocog alfa provided positive top-line results for treating patients with severe Hemophilia

Research from Wake Forest shows patients are more comfortable sharing concerning matters when screened on a tablet app compared with speaking to a nurse.

An increase in annual prevalence of beneficiaries with diabetes was observed in those who had ≥1 claim for DME (1.0% to 3.3%) and DME/VTDR (2.8% to 4.3%).

A population-based cohort study with data from 1.9 million patients from South Korean suggests a diagnosis of NAFLD was associated with an increased risk of severe hypoglycemic events among patients with type 2 diabetes.

AGN-190584 showed superiority in efficacy over vehicle in mesopic DCNVA on day 30 with an acceptable safety profile for patients with presbyopia.

In an interview, lead investigator and expert Dr. Martin Kolb discusses his new phase 2b HZN-825 trial and what it's like treating the rare disease.

A cross-sectional study of more than 70k women suggests those with long or irregular menstrual cycles were at a 22% greater risk of NAFLD.

The University of Colorado expert joins for a 5-part interview on making sense of the boom of new agents and care strategies.

The Yale Associate Chief of Cardiovascular Medicine discusses improved use of available drug classes, as well as the potential approval for omecamtiv mecarbil.